Introduction

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

In the clean energy revolution from national grid, helen skelton looks at the huge progress we're all making towards cleaner energy to help save our planet. Noah baker talks about yet other vaccine trial this week that's just come out. And friend of the nature poca ali dolgan alhow good gives his take on 19 new developments in science and medicine.

After a slew of wildly successful vaccine trials, this week marked a more underwhelming result. The third mRNA vaccine to complete phase three trials, developed by CureVac, is just 47% effective at staving off disease according to preliminary data. This is a stark contrast with previous mRNA vaccines from Moderna and Pfizer BioNtec which returned around twice that efficacy in their trials. In this episode of Coronapod, we ask why the CureVac vaccine has faltered, and what this might mean for the future of the pandemic and mRNA vaccine development.

News: CureVac COVID vaccine let-down spotlights mRNA design challenges

News Feature: How COVID unlocked the power of RNA vaccines

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.